US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 2.130
  • +0.030+1.43%
Close Apr 26 16:00 ET
  • 2.130
  • 0.0000.00%
Post 16:00 ET
56.22MMarket Cap-2393P/E (TTM)

Immix Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immix Biopharma Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.24

+11.11%
Analyst Rating

No Data

Immix Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--------
--------
--------

Unlock Free Earnings Estimates

Immix Biopharma Earnings Reports

  • Immix Biopharma | 10-K: Annual report

    Mar 29 16:09 ET

  • Immix Biopharma: Q3 2023 Earnings Report

    Nov 9, 2023 20:24 ET

  • Immix Biopharma | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 16:30 ET

  • Immix Biopharma | 10-Q: Q1 2023 Earnings Report

    May 12, 2023 17:01 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg